Dr. Dennis Erb has a comprehensive knowledge of the pharmaceutical industry including leadership positions spanning across Research & Development and Manufacturing. During the course of his 30+ year career, Dennis was directly involved in the approval of 18 original New Drug Applications, led MSD's Research and Development organization in Japan, and served as the CEO for CRESTOVO. Dennis earned his Ph.D. in pharmaceutics from the University of Iowa in 1984.  He returned to the College of Pharmacy in 2019 to serve as the Managing Director of UI Pharmaceuticals.

Samantha graduated from the University of Northern Iowa with a B.S. in Chemistry in 1994, since then she has been involved in potent compound handling in both laboratory settings and production environments. Beginning her career at a pharmaceutical ingredient and fine chemical manufacturer, Samantha was responsible for the analytical testing and development of manufacturing processes for a variety of chemicals, pharmaceutical intermediates, and APIs. She has worked from the development stage through full-scale production under cGMP regulations and been with UIP since 2003.

Bindu Gottam has over 14 years of experience in pharmaceutical product and process development, lifecycle management, scale-up, technology transfer, manufacturing, quality management, and regulatory compliance. Her extensive knowledge in pre-formulation and formulations, analytical, and regulatory areas led to over 20 FDA approvals of several dosage forms, including tablets, capsules, oral solutions, suspensions, topical, transdermal, and sterile products. Bindu earned her bachelor’s degree in pharmaceutical sciences from India, holds a master’s degree in chemistry, an MBA from the University of Colorado, Denver, and certification in US regulatory affairs.

Jeff graduated with a B.S. in Cell Biology from the University of Iowa in 1993 and has been working for UI Pharmaceuticals since 1991. Jeff started working in the analytical laboratory performing in-process, finished product and stability analyses of various pharmaceutical products including sterile injectables, oral liquids and solids, and topical semisolids and liquid products. In 2011 he transferred to Quality Assurance as a manager and assisted in supervising the quality management systems associated with drug product manufacturing and testing. In 2017 Jeff assumed the Director position in Quality Assurance. He is currently in charge of Quality Assurance reviewers, Materials Management and Inspection and Label Control.  

Ryan joined UIP in 2023 to lead and grow the sterile and non-sterile groups, including the sterile manufacturing facility at the new College of Pharmacy Building (CPB). After graduating with a BS biotechnology from Cal Poly Pomona, Ryan grew as a technical and people leader at Amphastar Pharmaceuticals, Johnson & Johnson, and TriRX Pharmaceutical Services. He brings experience managing continuous 24/7 operations in sterile and non-sterile FDA-regulated manufacturing plants, as well as Manufacturing Science & Technology (MSAT).